NorthWest Health Prop Real Est Inv Trust (NWH.UN) Stock Forecast & Price Target

C$5.15

+0.03 (+0.59%)

(As of 07/26/2024 ET)

Stock Analysis Analyst Forecasts Chart Competitors Headlines

NorthWest Health Prop Real Est Inv Trust - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 7 Analyst Ratings

Based on 7 Wall Street analysts who have issued ratings for NorthWest Health Prop Real Est Inv Trust in the last 12 months, the stock has a consensus rating of "Hold." Out of the 7 analysts, 5 have given a hold rating, and 2 have given a buy rating for NWH.UN.

Consensus Price Target

C$6.46
25.52% Upside

High Forecast	C$9.50
Average Forecast	C$6.46
Low Forecast	C$5.25

According to the 7 analysts' twelve-month price targets for NorthWest Health Prop Real Est Inv Trust, the average price target is C$6.46. The highest price target for NWH.UN is C$9.50, while the lowest price target for NWH.UN is C$5.25. The average price target represents a forecasted upside of 25.52% from the current price of C$5.15.

Type	Current Forecast 7/28/23 to 7/27/24	1 Month Ago 6/28/23 to 6/27/24	3 Months Ago 4/29/23 to 4/28/24	1 Year Ago 7/28/22 to 7/28/23
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	1 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	5 Hold rating(s)	4 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	C$6.46	C$6.46	C$6.29	C$10.07
Forecasted Upside	25.52% Upside	26.41% Upside	28.85% Upside	24.45% Upside

Get NorthWest Health Prop Real Est Inv Trust Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for NWH.UN and its competitors with MarketBeat's FREE daily newsletter.

Ad Unstoppable Prosperity

“Generational Bull Run” Incoming

LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.

You can find out what they are by clicking here now.

NWH.UN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NWH.UN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

NorthWest Health Prop Real Est Inv Trust Stock vs. The Competition

Type	NorthWest Health Prop Real Est Inv Trust	Real Estate Companies
Consensus Rating Score	2.29	2.49
Consensus Rating	Hold	Hold
News Sentiment Rating	Very Positive News	Neutral News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
5/27/2024	BMO Capital Markets 3 of 5 stars	Boost Target	Market Perform	C$5.00 ➝ C$5.25	+2.14%
5/16/2024	CIBC 3 of 5 stars	Boost Target	Neutral	C$5.00 ➝ C$5.75	+7.88%
5/16/2024	National Bankshares 1 of 5 stars	Boost Target	Sector Perform	C$5.25 ➝ C$5.75	+7.88%
3/21/2024	Cormark Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Buy
11/17/2023	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Sector Perform ➝ Sector Perform	C$6.00 ➝ C$5.50	+25.00%
10/10/2023	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Sector Perform	C$8.00 ➝ C$6.50	+27.45%
Get the Latest News and Ratings for NWH.UN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and its competitors with MarketBeat's FREE daily newsletter.
10/2/2023	Laurentian Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Buy ➝ Speculative Buy	C$9.00 ➝ C$7.00	+45.23%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 05:57 AM ET.

NWH.UN Forecast - Frequently Asked Questions

What is NorthWest Health Prop Real Est Inv Trust's forecast for 2024?: According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for NorthWest Health Prop Real Est Inv Trust is C$6.46, with a high forecast of C$9.50 and a low forecast of C$5.25.
Should I buy or sell NorthWest Health Prop Real Est Inv Trust stock right now?: 7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for NorthWest Health Prop Real Est Inv Trust in the last twelve months. There are currently 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NWH.UN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NWH.UN, but not buy additional shares or sell existing shares.
Does NorthWest Health Prop Real Est Inv Trust's stock price have much upside?: According to analysts, NorthWest Health Prop Real Est Inv Trust's stock has a predicted upside of 26.41% based on their 12-month stock forecasts.
What analysts cover NorthWest Health Prop Real Est Inv Trust?: NorthWest Health Prop Real Est Inv Trust has been rated by research analysts at BMO Capital Markets, CIBC, and National Bankshares in the past 90 days.
Do Wall Street analysts like NorthWest Health Prop Real Est Inv Trust more than its competitors?: Analysts like NorthWest Health Prop Real Est Inv Trust less than other "real estate" companies. The consensus rating score for NorthWest Health Prop Real Est Inv Trust is 2.29 while the average consensus rating score for "real estate" companies is 2.49. Learn more on how NWH.UN compares to other companies.